πŸ‡ΊπŸ‡Έ FDA
Patent

US 9708247

Modulators of the eIF2alpha pathway

granted A61KA61K31/165A61K31/4192

Quick answer

US patent 9708247 (Modulators of the eIF2alpha pathway) held by The Regents of the University of California expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/165, A61K31/4192, A61P, A61P25/00